tradingkey.logo
tradingkey.logo
Search

National Research Corp

NRC
Add to Watchlist
22.400USD
+0.060+0.27%
Close 07/02, 13:00ETQuotes delayed by 15 min
507.07MMarket Cap
55.95P/E TTM

TradingKey Stock Score of National Research Corp

Currency: USD Updated: 2026-07-02

Key Insights

National Research Corp's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 62 out of 161 in the Professional & Commercial Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 23.00.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

National Research Corp's Score

Industry at a Glance

Industry Ranking
62 / 161
Overall Ranking
164 / 4565
Industry
Professional & Commercial Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

National Research Corp Highlights

StrengthsRisks
National Research Corporation, doing business as NRC Health, is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Its digital solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience, which can be implemented both collectively as an enterprise solution or individually to meet specific needs within the organization. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools. Its Reputation solutions allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs better consumer decision-making.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 45.67%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 45.67%.
Overvalued
The company’s latest PE is 55.95, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 12.06M shares, decreasing 6.40% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 860.95K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.72.

Analyst Rating

Based on 1 analysts
Buy
Current Rating
23.000
Target Price
+2.95%
Upside Space

FAQs

How does TradingKey generate the Stock Score of National Research Corp?

The TradingKey Stock Score provides a comprehensive assessment of National Research Corp based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of National Research Corp’s performance and outlook.

How do we generate the financial health score of National Research Corp?

To generate the financial health score of National Research Corp, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects National Research Corp's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of National Research Corp.

How do we generate the company valuation score of National Research Corp?

To generate the company valuation score of National Research Corp, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare National Research Corp’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of National Research Corp’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of National Research Corp.

How do we generate the earnings forecast score of National Research Corp?

To calculate the earnings forecast score of National Research Corp, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on National Research Corp’s future.

How do we generate the price momentum score of National Research Corp?

When generating the price momentum score for National Research Corp, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of National Research Corp’s prices. A higher score indicates a more stable short-term price trend for National Research Corp.

How do we generate the institutional confidence score of National Research Corp?

To generate the institutional confidence score of National Research Corp, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about National Research Corp’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of National Research Corp.

How do we generate the risk management score of National Research Corp?

To assess the risk management score of National Research Corp, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of National Research Corp’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of National Research Corp.